BIOGEN (DENMARK) A/S: Financial statements 2013
CVR: 21682977
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
BIOGEN (DENMARK) A/S (CVR 21682977) has filed annual accounts for 2013. In 2013, the company reported revenue of DKK 204,862,605 and a net result of DKK 5,592,430. The profit margin was 2.7%. Equity in the 2013 report amounted to DKK 40,304,052. The solvency ratio was 35.7%. The company had 25 employees in the financial year.
- Revenue
- DKK 204,862,605
- Gross Profit
- DKK 64,869,828
- Profit/Loss
- DKK 5,592,430
- Equity
- DKK 40,304,052
- Total Assets
- DKK 112,745,815
- Employees
- 25
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
BIOGEN (DENMARK) A/S has published its annual report for 2012.
About BIOGEN (DENMARK) A/S
BIOGEN (DENMARK) A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 1999. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named BIOGEN IDEC (DENMARK) A/S. The management consists of Erik Magnus Bodin. The board consists of Neil Raymond Sisak (chair), Allan Frank Fischer Petersen, Erik Magnus Bodin and Sergio Ferreira da Silva Teixeira. The company is owned by Biogen Netherlands B.V.. The company has 13 employees (2026). In 2025, the company reported revenue of DKK 178,728,185 and a net result of DKK 5,563,672 compared with DKK 7,526,703 the year before. Equity in the 2025 report amounted to DKK 151,886,117.